Shenyang Xingqi Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, primarily focused on the research, development, production, and sale of chemical medications. The company specializes in providing active pharmaceutical ingredients (APIs) and a broad range of finished pharmaceutical products that cater to various therapeutic categories. The firm's portfolio includes treatments for cardiovascular, infectious diseases, and digestive system conditions, reflecting its commitment to enhancing healthcare outcomes. Shenyang Xingqi's operations are underscored by a robust commitment to quality and safety, adhering to stringent international standards. The company significantly impacts the health sector by contributing to the availability of essential medications both domestically and internationally. With a strategic emphasis on innovation, collaboration, and expansion, Shenyang Xingqi Pharmaceutical Co., Ltd. plays a vital role in advancing pharmaceutical sciences and meeting the growing healthcare needs of modern society.
Markedsdata leveret af TwelveData og Morningstar